Royal Philips NV Sponsored ADR Aktie News

February 3, 2026 Co-funded by the EU's Innovative Health Initiative (IHI), the Philips-coordinated research consortium will combine advanced medical imaging, robotic guidance technologies, and AI to standardize and enhance the precision of minimally invasive cancer treatments Five-year research program with total budget of EUR 23.9 million includes five clinical studies to validate the technica...

Philips is recognized for its market-leading innovation and comprehensive digital pathology ecosystem, driving global transformation in diagnostics and healthcare informatics SAN ANTONIO, Jan. 29, 2026 /PRNewswire/ -- Frost & Sullivan  is pleased to announce that Philips  has been awarded the 2025 Global Enabling Technology Leadership Recognition in the Digital Pathology–Healthcare Informatics ...

Philips benefits from sector-wide valuation tailwinds, anticipated MedTech revival in 2026, and accelerating organic revenue growth. AI integration, highlighted by the SpectraWAVE acquisition, is set to drive higher growth, margin expansion, and capital efficiency for PHG. European healthcare has lagged for three years, leaving valuations attractive; we expect 2026 to mark a re-engagement phase...

RIYADH, Kingdom of Saudi Arabia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Kiwi Information Technology Co. Ltd. (Kiwi) showcased Philips Home Access solutions at Big 5 Construct Saudi 2026, underscoring its continued expansion of intelligent access solutions across Saudi Arabia's retail and commercial sectors.

January 21, 2026 Highest-ranking medical technology company recognized in the Clarivate Top 100 Global Innovators list for 2026 Innovations for healthcare professionals and consumers that support better care delivery and improve people's health and well-being Industry-leading commitment to R&D, with over EUR 1.7 billion invested annually, equivalent to approximately 9% of sales Amsterdam, the N...

WASHINGTON--(BUSINESS WIRE)--Emergency Care Holdings, backed by Bridgefield Capital, acquired Philips Emergency Care, establishing a scalable platform in a $26B market.

Philips N.V. (PHG) is rated a conservative 'Buy' with a maintained price target, reflecting 20%+ annualized upside potential. PHG's leadership in imaging, healthcare AI, and a strong moat in diagnosis and treatment underpin the investment case despite historical missteps. Litigation resolution, productivity initiatives, and a 40–50% dividend payout target support margin expansion and forward ea...

December 15, 2025 Acquisition of SpectraWAVE's next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE's technologies ha...